FDA Import Refusal SCS-5328569-4/10003/3 — TARLOCHAN SINGH
The FDA refused shipment SCS-5328569-4/10003/3 from TARLOCHAN SINGH (India) on Feb 26, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Feb 26, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JDY08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75